Literature DB >> 27112260

From Diagnosis to Treatment: Clinical Applications of Nanotechnology in Thoracic Surgery.

Christopher S Digesu1, Sophie C Hofferberth1, Mark W Grinstaff2, Yolonda L Colson3.   

Abstract

Nanotechnology is an emerging field with potential as an adjunct to cancer therapy, particularly thoracic surgery. Therapy can be delivered to tumors in a more targeted fashion, with less systemic toxicity. Nanoparticles may aid in diagnosis, preoperative characterization, and intraoperative localization of thoracic tumors and their lymphatics. Focused research into nanotechnology's ability to deliver both diagnostics and therapeutics has led to the development of nanotheranostics, which promises to improve the treatment of thoracic malignancies through enhanced tumor targeting, controlled drug delivery, and therapeutic monitoring. This article reviews nanoplatforms, their unique properties, and the potential for clinical application in thoracic surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung cancer; Nanotechnology; Nanotheranostics; Thoracic surgery

Mesh:

Year:  2016        PMID: 27112260      PMCID: PMC4851727          DOI: 10.1016/j.thorsurg.2015.12.009

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  84 in total

Review 1.  Current surgical therapy for stage IIIA (N2) non-small cell lung cancer.

Authors:  Jane Yanagawa; Valerie W Rusch
Journal:  Semin Thorac Cardiovasc Surg       Date:  2011

Review 2.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

3.  Wide-field multiplexed imaging of EGFR-targeted cancers using topical application of NIR SERS nanoprobes.

Authors:  Rupananda J Mallia; Patrick Z McVeigh; Carl J Fisher; Israel Veilleux; Brian C Wilson
Journal:  Nanomedicine (Lond)       Date:  2014-07-21       Impact factor: 5.307

Review 4.  CT-2103: a novel macromolecular taxane with potential advantages compared with conventional taxanes.

Authors:  Corey J Langer
Journal:  Clin Lung Cancer       Date:  2004-12       Impact factor: 4.785

5.  Nanoparticle migration and delivery of Paclitaxel to regional lymph nodes in a large animal model.

Authors:  Onkar V Khullar; Aaron P Griset; Summer L Gibbs-Strauss; Lucian R Chirieac; Kimberly A V Zubris; John V Frangioni; Mark W Grinstaff; Yolonda L Colson
Journal:  J Am Coll Surg       Date:  2012-01-05       Impact factor: 6.113

6.  Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.

Authors:  Vivien W Chen; Bernardo A Ruiz; Mei-Chin Hsieh; Xiao-Cheng Wu; Lynn A G Ries; Denise R Lewis
Journal:  Cancer       Date:  2014-12-01       Impact factor: 6.860

7.  Preoperative staging of lung cancer with combined PET-CT.

Authors:  Barbara Fischer; Ulrik Lassen; Jann Mortensen; Søren Larsen; Annika Loft; Anne Bertelsen; Jesper Ravn; Paul Clementsen; Asbjørn Høgholm; Klaus Larsen; Torben Rasmussen; Susanne Keiding; Asger Dirksen; Oke Gerke; Birgit Skov; Ida Steffensen; Hanne Hansen; Peter Vilmann; Grete Jacobsen; Vibeke Backer; Niels Maltbaek; Jesper Pedersen; Henrik Madsen; Henrik Nielsen; Liselotte Højgaard
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

Review 8.  In vivo studies of nanostructure-based photosensitizers for photodynamic cancer therapy.

Authors:  Siew Hui Voon; Lik Voon Kiew; Hong Boon Lee; Siang Hui Lim; Mohamed Ibrahim Noordin; Anyanee Kamkaew; Kevin Burgess; Lip Yong Chung
Journal:  Small       Date:  2014-08-28       Impact factor: 13.281

9.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

10.  Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent.

Authors:  Cristian T Badea; Khannan K Athreya; Gabriela Espinosa; Darin Clark; A Paiman Ghafoori; Yifan Li; David G Kirsch; G Allan Johnson; Ananth Annapragada; Ketan B Ghaghada
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

View more
  1 in total

1.  New perspectives in nanotherapeutics for chronic respiratory diseases.

Authors:  Adriana Lopes da Silva; Fernanda Ferreira Cruz; Patricia Rieken Macedo Rocco; Marcelo Marcos Morales
Journal:  Biophys Rev       Date:  2017-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.